Co-delivery of dual chemo-drugs with precisely controlled, high drug loading polymeric micelles for synergistic anti-cancer therapy

被引:44
作者
Wu, Yuchen [1 ]
Lv, Shixian [1 ,2 ]
Li, Yongjuan [1 ]
He, Hua [1 ]
Ji, Yong [3 ]
Zheng, Mingfeng [3 ]
Liu, Yong [1 ]
Yin, Lichen [1 ]
机构
[1] Soochow Univ, Inst Funct Nano & Soft Mat FUNSOM, Jiangsu Key Lab Carbon Based Funct Mat & Devices, Collaborat Innovat Ctr Suzhou Nano Sci & Technol, Suzhou 215123, Peoples R China
[2] Univ Illinois, Dept Mat Sci & Engn, Urbana, IL 61801 USA
[3] Nanjing Med Univ, Wuxi Peoples Hosp, Dept Cardiothorac Surg, Wuxi 214023, Jiangsu, Peoples R China
基金
中国国家自然科学基金;
关键词
ANTITUMOR-ACTIVITY; CANCER-THERAPY; BREAST-CANCER; NANOPARTICLES; DOXORUBICIN; COMBINATIONS; CHEMOTHERAPY; PACLITAXEL; IRINOTECAN; EFFICACY;
D O I
10.1039/c9bm01662g
中图分类号
TB3 [工程材料学]; R318.08 [生物材料学];
学科分类号
0805 ; 080501 ; 080502 ;
摘要
Simultaneous delivery of multiple chemotherapeutics using polymeric micelles often suffers from unsatisfactory drug loading, drug ratio management, and drug release. Herein, we report a feasible strategy to prepare micelles with ultra-high drug loading and a controllable drug ratio through the introduction of donor-acceptor interactions between drugs and polymeric carriers. An amphiphilic copolymer modified with phenylboronic acid moieties on the hydrophobic segment was synthesized, in which phenylboronic acid functioned as an electron acceptor and formed donor-acceptor coordination with doxorubicin (DOX) and irinotecan (IR). The obtained dual-drug-loaded micelles possessed high drug loading (up to 50%), a tunable drug ratio, and a uniform particle size. Furthermore, both of the encapsulated drug cargoes could be effectively and selectively released in cancer cells with over-produced reactive oxygen species (ROS), and thus the drug-loaded micelles exhibited synergistic anticancer efficacy and reduced systemic toxicity.
引用
收藏
页码:949 / 959
页数:11
相关论文
共 55 条
[11]   Combination therapy: Opportunities and challenges for polymer-drug conjugates as anticancer nanomedicines [J].
Greco, Francesca ;
Vicent, Maria J. .
ADVANCED DRUG DELIVERY REVIEWS, 2009, 61 (13) :1203-1213
[12]   Antitumor Activity of Triolimus: A Novel Multidrug-Loaded Micelle Containing Paclitaxel, Rapamycin, and 17-AAG [J].
Hasenstein, Jason R. ;
Shin, Ho-Chul ;
Kasmerchak, Kelsey ;
Buehler, Darya ;
Kwon, Glen S. ;
Kozak, Kevin R. .
MOLECULAR CANCER THERAPEUTICS, 2012, 11 (10) :2233-2242
[13]   Effective and Selective Anti-Cancer Protein Delivery via All-Functions-in-One Nanocarriers Coupled with Visible Light-Responsive, Reversible Protein Engineering [J].
He, Hua ;
Chen, Yongbing ;
Li, Yongjuan ;
Song, Ziyuan ;
Zhong, Yinan ;
Zhu, Rongying ;
Cheng, Jianjun ;
Yin, Lichen .
ADVANCED FUNCTIONAL MATERIALS, 2018, 28 (14)
[14]   Recent advances of cocktail chemotherapy by combination drug delivery systems [J].
Hu, Quanyin ;
Sun, Wujin ;
Wang, Chao ;
Gu, Zhen .
ADVANCED DRUG DELIVERY REVIEWS, 2016, 98 :19-34
[15]   Block copolymer micelles for drug delivery: Design, characterization and biological significance [J].
Kataoka, Kazunori ;
Harada, Atsushi ;
Nagasaki, Yukio .
ADVANCED DRUG DELIVERY REVIEWS, 2012, 64 :37-48
[16]   Engineering of self-assembled nanoparticle platform for precisely controlled combination drug therapy [J].
Kolishetti, Nagesh ;
Dhar, Shanta ;
Valencia, Pedro M. ;
Lin, Lucy Q. ;
Karnik, Rohit ;
Lippard, Stephen J. ;
Langer, Robert ;
Farokhzad, Omid C. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (42) :17939-17944
[17]   Final results of a phase III randomized trial of CPX-351 versus 7+3 in older patients with newly diagnosed high risk (secondary) AML. [J].
Lancet, Jeffrey E. ;
Uy, Geoffrey L. ;
Cortes, Jorge E. ;
Newell, Laura F. ;
Lin, Tara L. ;
Ritchie, Ellen K. ;
Stuart, Robert K. ;
Strickland, Stephen Anthony ;
Hogge, Donna ;
Solomon, Scott R. ;
Stone, Richard M. ;
Bixby, Dale L. ;
Kolitz, Jonathan E. ;
Schiller, Gary J. ;
Wieduwilt, Matthew Joseph ;
Ryan, Daniel H. ;
Hoering, Antje ;
Chiarella, Michael ;
Louie, Arthur Chin ;
Medeiros, Bruno C. .
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
[18]   Current Progress in Reactive Oxygen Species (ROS)-Responsive Materials for Biomedical Applications [J].
Lee, Sue Hyun ;
Gupta, Mukesh K. ;
Bang, Jae Beum ;
Bae, Hojae ;
Sung, Hak-Joon .
ADVANCED HEALTHCARE MATERIALS, 2013, 2 (06) :908-915
[19]   Integration of phospholipid-hyaluronic acid-methotrexate nanocarrier assembly and amphiphilic drug-drug conjugate for synergistic targeted delivery and combinational tumor therapy [J].
Li, Yang ;
Zhang, Huabing ;
Chen, Yilin ;
Ma, Jinyuan ;
Lin, Jinyan ;
Zhang, Yinying ;
Fan, Zhongxiong ;
Su, Guanghao ;
Xie, Liya ;
Zhu, Xuan ;
Hou, Zhenqing .
BIOMATERIALS SCIENCE, 2018, 6 (07) :1818-1833
[20]   Photodynamic therapy-triggered on-demand drug release from ROS-responsive core-cross-linked micelles toward synergistic anti-cancer treatment [J].
Li, Yongjuan ;
Hu, Jian ;
Liu, Xun ;
Liu, Yong ;
Lv, Shixian ;
Dang, Juanjuan ;
Ji, Yong ;
He, Jinlin ;
Yin, Lichen .
NANO RESEARCH, 2019, 12 (05) :999-1008